SightGlass spectacle lenses slow pediatric myopia progression at 2 years

October 21, 2021

1 minute reading

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted

Enter your email address to receive an email when there are new articles on . ” data-action = “subscribe” > Subscribe

We were unable to process your request. Try again later. If this problem persists, please contact customerservice@slackinc.com.

Back to Healio

SightGlass Vision Diffusion Optics Technology lenses slowed the progression of myopia in children after 2 years, according to a press release from CooperVision.

The randomized CYPRESS clinical trial enrolled 256 children aged 6 to 10 years with myopia between –0.75 D and –4.5 D. By the end of the 2 year period, 85% of the children who had wearing the spectacle lenses full-time had less than 1 D of myopia progression and 41% showed no clinically meaningful progression in refractive error compared to 17% in the control group.

Joe Rappon

“Our team has focused in particular on advancing medical science to not only correct children’s vision, but also slow the progression of myopia,” Joe Rappon, OD, MS, FAAO, chief medical officer at SightGlass Vision, said in the release. “By applying our Diffusion Optics technology to eyeglass lenses, myopia management is easy to integrate into eye care practices and easily become part of children’s daily lives.”

The study is now entering its third year and the lenses will be available in the Netherlands this month, the company said.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted

Enter your email address to receive an email when there are new articles on . ” data-action = “subscribe” > Subscribe

We were unable to process your request. Try again later. If this problem persists, please contact customerservice@slackinc.com.

Back to Healio

Comments are closed.